EW
42
-6
LYB
50
4
EQIX
54
-4
MTCH
48
-5
COST
70
-4
CSCO
58
4
TRIP
49
-15
HSIC
54
3
LRCX
61
2
HPE
29
4
GWW
55
4
REGN
68
-3
CAH
40
-3
ACN
45
2
NDAQ
44
-5
MDLZ
50
-5
SLB
42
-2
AAP
32
2
K
53
3
GM
80
-3
EW
42
-6
LYB
50
4
EQIX
54
-4
MTCH
48
-5
COST
70
-4
CSCO
58
4
TRIP
49
-15
HSIC
54
3
LRCX
61
2
HPE
29
4
GWW
55
4
REGN
68
-3
CAH
40
-3
ACN
45
2
NDAQ
44
-5
MDLZ
50
-5
SLB
42
-2
AAP
32
2
K
53
3
GM
80
-3
Financhill
Back

Ultragenyx Pharmaceutical Quote, Financials, Valuation and Earnings

The little-known AI stock you need to read about now...

Get the name - FREE.
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
41.21
Seasonality Move:
13.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly

Ultragenyx Pharmaceutical Price Quote

$41.21
-0.35 (-0.84%)
(Updated: May 9, 2024 at 6:55 PM ET)

Ultragenyx Pharmaceutical Key Stats

Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell
Day range:
$41.00 - $42.09
52-week range:
$31.52 - $54.98
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
7.23
P/B ratio:
24.63%
Volume:
731.2K
Avg. volume:
773.7K
1-year change:
-11.67%
Market cap:
$3.5B
Revenue:
$434.2M
EPS:
$-8.03

How Much Does Ultragenyx Pharmaceutical Make?

Is Ultragenyx Pharmaceutical Growing As A Company?

Ultragenyx Pharmaceutical Stock Price Performance

What Is Ultragenyx Pharmaceutical 52-Week High & Low?

Ultragenyx Pharmaceutical Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Ultragenyx Pharmaceutical?

Is Ultragenyx Pharmaceutical Cash Flow Positive?

  • What Is RARE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$508.7M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $388.8M
  • What Is Ultragenyx Pharmaceutical’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $151.1M

Ultragenyx Pharmaceutical Return On Invested Capital

  • Is Management Doing A Good Job?
    RARE return on invested capital is -384.83%
  • What Is Ultragenyx Pharmaceutical Return On Assets?
    ROA measures how assets are converting to revenues and is -45.56%
  • What Is RARE Return On Equity?
    ROE is a measure of profitability and is -384.83%

Ultragenyx Pharmaceutical Earnings Date & Stock Price

Ultragenyx Pharmaceutical Competitors

Ultragenyx Pharmaceutical Dividend Yield

Data Unavailable

Ultragenyx Pharmaceutical Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -18.01%
Revenue: 8.3% -6.53%

Analyst Recommendations

Buy Recommendations: 13
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 89.00
Upside from Last Price: 114.15%

Major Shareholders

  • How many RARE shares are owned by institutional investors?
    124M RARE shares are owned by institutional investors
  • How many RARE shares are owned by insiders?
    1.8M RARE shares are owned by insiders